BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 11756158)

  • 1. STAT5 promotes multilineage hematolymphoid development in vivo through effects on early hematopoietic progenitor cells.
    Snow JW; Abraham N; Ma MC; Abbey NW; Herndier B; Goldsmith MA
    Blood; 2002 Jan; 99(1):95-101. PubMed ID: 11756158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5.
    Bunting KD; Bradley HL; Hawley TS; Moriggl R; Sorrentino BP; Ihle JN
    Blood; 2002 Jan; 99(2):479-87. PubMed ID: 11781228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic-repopulating defects from STAT5-deficient bone marrow are not fully accounted for by loss of thrombopoietin responsiveness.
    Bradley HL; Couldrey C; Bunting KD
    Blood; 2004 Apr; 103(8):2965-72. PubMed ID: 15070672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell intrinsic defects in cytokine responsiveness of STAT5-deficient hematopoietic stem cells.
    Bradley HL; Hawley TS; Bunting KD
    Blood; 2002 Dec; 100(12):3983-9. PubMed ID: 12393407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
    Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
    Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice.
    Snow JW; Abraham N; Ma MC; Goldsmith MA
    Exp Hematol; 2003 Dec; 31(12):1247-52. PubMed ID: 14662331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of tolerance and autoimmunity affecting multiple organs in STAT5A/5B-deficient mice.
    Snow JW; Abraham N; Ma MC; Herndier BG; Pastuszak AW; Goldsmith MA
    J Immunol; 2003 Nov; 171(10):5042-50. PubMed ID: 14607901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant negative mutants implicate STAT5 in myeloid cell proliferation and neutrophil differentiation.
    Ilaria RL; Hawley RG; Van Etten RA
    Blood; 1999 Jun; 93(12):4154-66. PubMed ID: 10361113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis.
    Couldrey C; Bradley HL; Bunting KD
    Blood; 2005 Feb; 105(4):1476-83. PubMed ID: 15498858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The granulocyte colony-stimulating factor receptor supports erythroid differentiation in the absence of the erythropoietin receptor or Stat5.
    Millot GA; Svinarchuk F; Lacout C; Vainchenker W; Dumenil D
    Br J Haematol; 2001 Feb; 112(2):449-58. PubMed ID: 11167846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transducer and activator of transcription 5a (STAT5a) is required for eosinophil differentiation of human cord blood-derived CD34+ cells.
    Buitenhuis M; Baltus B; Lammers JW; Coffer PJ; Koenderman L
    Blood; 2003 Jan; 101(1):134-42. PubMed ID: 12393707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transgenic bcl-2 is not sufficient to rescue all hematolymphoid defects in STAT5A/5B-deficient mice.
    Snow JW; Abraham N; Ma MC; Bronson SK; Goldsmith MA
    Exp Hematol; 2003 Dec; 31(12):1253-8. PubMed ID: 14662332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of antisense oligonucleotides against STAT5 on the regulation of normal haematopoiesis in a bone marrow model.
    Baśkiewicz-Masiuk M; Paczkowski M; Machaliński B
    Cell Prolif; 2004 Jun; 37(3):231-45. PubMed ID: 15144500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A role for Stat5 in CD8+ T cell homeostasis.
    Kelly J; Spolski R; Imada K; Bollenbacher J; Lee S; Leonard WJ
    J Immunol; 2003 Jan; 170(1):210-7. PubMed ID: 12496402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gab2 promotes hematopoietic stem cell maintenance and self-renewal synergistically with STAT5.
    Li G; Wang Z; Miskimen KL; Zhang Y; Tse W; Bunting KD
    PLoS One; 2010 Feb; 5(2):e9152. PubMed ID: 20161778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT5 requires the N-domain to maintain hematopoietic stem cell repopulating function and appropriate lymphoid-myeloid lineage output.
    Li G; Wang Z; Zhang Y; Kang Z; Haviernikova E; Cui Y; Hennighausen L; Moriggl R; Wang D; Tse W; Bunting KD
    Exp Hematol; 2007 Nov; 35(11):1684-94. PubMed ID: 17976521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both stat5a and stat5b are required for antigen-induced eosinophil and T-cell recruitment into the tissue.
    Kagami Si; Nakajima H; Kumano K; Suzuki K; Suto A; Imada K; Davey HW; Saito Y; Takatsu K; Leonard WJ; Iwamoto I
    Blood; 2000 Feb; 95(4):1370-7. PubMed ID: 10666213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts.
    Socolovsky M; Nam H; Fleming MD; Haase VH; Brugnara C; Lodish HF
    Blood; 2001 Dec; 98(12):3261-73. PubMed ID: 11719363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
    Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
    Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stat5 expression is critical for mast cell development and survival.
    Shelburne CP; McCoy ME; Piekorz R; Sexl V; Roh KH; Jacobs-Helber SM; Gillespie SR; Bailey DP; Mirmonsef P; Mann MN; Kashyap M; Wright HV; Chong HJ; Bouton LA; Barnstein B; Ramirez CD; Bunting KD; Sawyer S; Lantz CS; Ryan JJ
    Blood; 2003 Aug; 102(4):1290-7. PubMed ID: 12714518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.